| Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide M Krampera, S Glennie, J Dyson, D Scott, R Laylor, E Simpson, F Dazzi Blood, The Journal of the American Society of Hematology 101 (9), 3722-3729, 2003 | 2291 | 2003 |
| Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells S Glennie, I Soeiro, PJ Dyson, EWF Lam, F Dazzi Blood 105 (7), 2821-2827, 2005 | 1606 | 2005 |
| Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle R Ramasamy, H Fazekasova, EWF Lam, I Soeiro, G Lombardi, F Dazzi Transplantation 83 (1), 71-76, 2007 | 642 | 2007 |
| Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation A Galleu, Y Riffo-Vasquez, C Trento, C Lomas, L Dolcetti, TS Cheung, ... Science translational medicine 9 (416), eaam7828, 2017 | 632 | 2017 |
| Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth R Ramasamy, EWF Lam, I Soeiro, V Tisato, D Bonnet, F Dazzi Leukemia 21 (2), 304-310, 2007 | 556 | 2007 |
| The Risk of Recurrent Venous Thromboembolism in Patients with an Arg506→Gln Mutation in the Gene for Factor V (Factor V Leiden) P Simioni, P Prandoni, AWA Lensing, A Scudeller, C Sardella, MH Prins, ... New England Journal of Medicine 336 (6), 399-403, 1997 | 549 | 1997 |
| The role of mesenchymal stem cells in haemopoiesis F Dazzi, R Ramasamy, S Glennie, SP Jones, I Roberts Blood reviews 20 (3), 161-171, 2006 | 528 | 2006 |
| International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials J Galipeau, M Krampera, J Barrett, F Dazzi, RJ Deans, J DeBruijn, ... Cytotherapy 18 (2), 151-159, 2016 | 517 | 2016 |
| Mesenchymal stem cells: the fibroblasts’ new clothes? MA Haniffa, MP Collin, CD Buckley, F Dazzi haematologica 94 (2), 258, 2008 | 474 | 2008 |
| Incidence of venous thromboembolism in families with inherited thrombophilia P Simioni, BJ Sanson, P Prandoni, D Tormene, PW Friederich, B Girolami, ... Thrombosis and haemostasis 81 (02), 198-202, 1999 | 460 | 1999 |
| Characterization and Clinical Application of Human CD34+ Stem/Progenitor Cell Populations Mobilized into the Blood by Granulocyte Colony‐Stimulating Factor MY Gordon, N Levičar, M Pai, P Bachellier, I Dimarakis, F Al‐Allaf, ... Stem cells 24 (7), 1822-1830, 2006 | 427 | 2006 |
| European LeukemiaNet criteria for failure or suboptimal response reliably identify patients with CML in early chronic phase treated with imatinib whose eventual outcome is poor D Marin, D Milojkovic, E Olavarria, JS Khorashad, H De Lavallade, ... Blood, The Journal of the American Society of Hematology 112 (12), 4437-4444, 2008 | 421 | 2008 |
| Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice T Ruutu, A Gratwohl, T De Witte, B Afanasyev, J Apperley, A Bacigalupo, ... Bone marrow transplantation 49 (2), 168-173, 2014 | 411 | 2014 |
| Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia F Dazzi, RM Szydlo, C Craddock, NCP Cross, J Kaeda, A Chase, ... Blood, The Journal of the American Society of Hematology 95 (1), 67-71, 2000 | 401 | 2000 |
| Limits to dark matter annihilation cross-section from a combined analysis of MAGIC and Fermi-LAT observations of dwarf satellite galaxies ML Ahnen, S Ansoldi, LA Antonelli, P Antoranz, A Babic, B Banerjee, ... arXiv preprint arXiv:1601.06590, 2016 | 371 | 2016 |
| Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment F Mussai, C De Santo, I Abu-Dayyeh, S Booth, L Quek, ... Blood, The Journal of the American Society of Hematology 122 (5), 749-758, 2013 | 342 | 2013 |
| Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia F Dazzi, RM Szydlo, NCP Cross, C Craddock, J Kaeda, E Kanfer, ... Blood, The Journal of the American Society of Hematology 96 (8), 2712-2716, 2000 | 332 | 2000 |
| The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells S Jones, N Horwood, A Cope, F Dazzi The Journal of Immunology 179 (5), 2824-2831, 2007 | 331 | 2007 |
| HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: inducing cell expansion and reversibly preventing multilineage differentiation M Krampera, A Pasini, A Rigo, MT Scupoli, C Tecchio, G Malpeli, ... Blood 106 (1), 59-66, 2005 | 288 | 2005 |
| The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function R Ramasamy, CK Tong, HF Seow, S Vidyadaran, F Dazzi Cellular immunology 251 (2), 131-136, 2008 | 284 | 2008 |
